BENAZEPRIL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Benazepril, and what generic alternatives are available?
Benazepril is a drug marketed by Amneal Pharms, Ani Pharms, Aurobindo Pharma, Chartwell Rx, Corepharma, Genpharm, Heritage Pharma, Prinston Inc, Rising, Sun Pharm Inds Ltd, Teva, Zydus Lifesciences, Apotex, Aurobindo Pharma Usa, Mylan Pharms Inc, and Sandoz. and is included in nineteen NDAs.
The generic ingredient in BENAZEPRIL is benazepril hydrochloride; hydrochlorothiazide. There are two drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the benazepril hydrochloride; hydrochlorothiazide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Benazepril
A generic version of BENAZEPRIL was approved as benazepril hydrochloride; hydrochlorothiazide by ANI PHARMS on February 11th, 2004.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for BENAZEPRIL?
- What are the global sales for BENAZEPRIL?
- What is Average Wholesale Price for BENAZEPRIL?
Summary for BENAZEPRIL
| US Patents: | 0 |
| Applicants: | 16 |
| NDAs: | 19 |
| Drug Prices: | Drug price information for BENAZEPRIL |
| Drug Sales Revenues: | Drug sales revenues for BENAZEPRIL |
| DailyMed Link: | BENAZEPRIL at DailyMed |



